blog
Handelsblatt
Super minister with execution issues: Lambrecht is running out of time on important projects
Shortly before the summer break, the CDU/CSU and SPD are aiming to finalise some unfinished coalition projects. One such project is reform of the German patent law.
IP2Innovate, which represents, among others, Adidas, BMW, Daimler, Deutsche Telekom and SAP, believes that effective modernization of German patent law is overdue, but possible. "Passing the law before the end of this legislative period is absolutely necessary to avert further damage to innovation, competitiveness and employment in Germany" - Ludwig von Reiche, IP2I Board Member, told Handelsblatt.
Share
Other press coverage
IP2Innovate
Multi-association letter to EVP Stéphane Séjourné on the IPRED modernisation
"We, the undersigned representatives of industry associations representing over 100 companies from various sectors (including automotive, information technology, semiconductors, software & services, AI, quantum technology, telecoms, communications and consumer goods), collectively holding more than 580.000 patents, and employing around 2,5 million people in the EU, urge the European Commission to take steps to modernise the 20-year-old Intellectual Property Rights Enforcement Directive (IPRED) in relation to proportionality of remedies for patent infringement, to ensure that the system is fit for purpose in the digital age and supports Europe’s competitiveness.
IP2Innovate
Contrary to EU law, courts across Europe consistently fail to consider proportionality in patent cases, new data reveals
BRUSSELS, 25 November 2021 – Between 2018 and 2020, courts in nine EU member states plus the UK and Norway, handed out injunctions automatically in 98% of patent cases in which an infringement was found, according to data sourced from Darts-ip, a Clarivate IP intelligence solution.
expansion.com
Apple y Microsoft instan a la UE a plantar cara a los ‘trolls’ de patentes. [Expansion | 17.01.2020]
35 companies signed a letter urging Brussels to take action against companies that buy patents with the sole purpose to make business out of them.